---
title: Anatomical and Biological Considerations to Determine Resectability in Pancreatic
  Cancer
date: '2024-02-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38339242/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240210170637&v=2.18.0
source: heidelberg[Affiliation]
description: Pancreatic ductal adenocarcinoma (PDAC) remains associated with poor
  outcomes with a 5-year survival of 12% across all stages of the disease. These poor
  outcomes are driven by a delay in diagnosis and an early propensity for systemic
  dissemination of the disease. Recently, aggressive surgical approaches involving
  complex vascular resections and reconstructions have become more common, thus allowing
  more locally advanced tumors to be resected. Unfortunately, however, even after
  the completion ...
disable_comments: true
---
Pancreatic ductal adenocarcinoma (PDAC) remains associated with poor outcomes with a 5-year survival of 12% across all stages of the disease. These poor outcomes are driven by a delay in diagnosis and an early propensity for systemic dissemination of the disease. Recently, aggressive surgical approaches involving complex vascular resections and reconstructions have become more common, thus allowing more locally advanced tumors to be resected. Unfortunately, however, even after the completion ...